{rfName}
Te

Indexed in

License and use

Citations

11

Altmetrics

Analysis of institutional authors

Rodriguez-Valero NCorresponding AuthorCamprubí-Ferrer DAuthorMarti-Soler HAuthorPinazo MjAuthorAlmuedo-Riera AAuthorRoldan MAuthorJimenez AAuthorMuñoz JAuthor

Share

May 20, 2022
Publications
>
Article
No

Telemedicine for international travelers through a Smartphone-based monitoring platform (Trip Doctor®)

Publicated to:Travel Medicine And Infectious Disease. 49 102356- - 2022-10-01 49(), DOI: 10.1016/j.tmaid.2022.102356

Authors: Rodriguez-Valero, N; Carbayo, ML; Camprubi-Ferrer, D; Marti-Soler, H; Sanchez, DC; Vladimirov, A; Pinazo, MJ; Almuedo-Riera, A; Roman, A; Vera, I; Roldan, M; de Alba, T; Jimenez, A; Gomez-Valverde, JJ; Oroz, ML; Munoz, J

Affiliations

CIBER BBN, Madrid, Spain - Author
Univ Barcelona C, Hosp Clin Barcelona, Dept Trop Med & Int Hlth, Barcelona Ctr Int Hlth Res CRESIB,ISGlobal, Barcelona 08036, Spain - Author
Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Dept Int Hlth,ISGlobal, Barcelona, Spain - Author
Univ Politecn Madrid, Biomed Image Technol Elect Engn, Madrid, Spain - Author

Abstract

Overall, more than 50% of international travelers develop symptoms while traveling and 55% of them seek medical assistance during the trip. We conducted a study to evaluate the usefulness of a Smartphone app called TRIP Doctor® to provide telemedicine to international travelers.Participants over 18 years old attending our travel clinic at Hospital Clinic in Barcelona were invited to participate during 2017-2019. After downloading the app, the health status of the traveler was monitored on a daily basis, providing specific medical advice and offering remote contact with specialized physicians through an integrated chat, if needed.From 449 users, 59 (13%) contacted for medical assistance through the app during the trip. Main reasons for telemedicine were diarrhea (25.7%), skin conditions (19.7%) and fever (12.1%). Among patients who contacted, 90% of the travelers did not require to be referred to a local doctor. Symptomatic treatment was the main treatment prescribed (38%). In a 14.7% of the cases a follow-up was not required, a 63.2% recovered and 22.1% were loss of follow-up. After a multivariate analysis, duration of trip >14 days was found to be the only factor associated with the use of telemedicine (OR 2.2, CI 95% 1.1-4.5, p?=?0.03).In conclusion, travelers using telemedicine travelled for longer periods of time and mostly contacted for mild symptoms which could be solved successfully by remote assistance with our specialized doctors.Copyright © 2022. Published by Elsevier Ltd.

Keywords

digital participatory surveillance systemmedical appsreal-time health recordingssmartphonetelehealthtravel medicineAdolescentAdultArticleControlled studyDiarrheaDigital participatory surveillance systemDisease predispositionEmporiatricsFemaleFeverFollow upHealth statusHumanHumansMajor clinical studyMaleMedical appsMedical careMiddle agedMobile applicationMobile applicationsOnline monitoringPalliative therapyPhysicianPhysiciansReal-time health recordingsSkin defectSkin diseaseSmartphoneSpainTelecareTeleconsultationTelehealthTelemedicineTravelTravel medicineTreatment outcomeYoung adult

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Travel Medicine And Infectious Disease due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 11/207, thus managing to position itself as a Q1 (Primer Cuartil), in the category Public, Environmental & Occupational Health. Notably, the journal is positioned above the 90th percentile.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 1.61, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-16, the following number of citations:

  • WoS: 2
  • Scopus: 4
  • Europe PMC: 4

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-16:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 26.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 43 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 5.55.
  • The number of mentions on the social network X (formerly Twitter): 8 (Altmetric).

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Rodriguez Valero, Natalia) and Last Author (MUÑOZ GUTIERREZ, JOSE).

the author responsible for correspondence tasks has been Rodriguez Valero, Natalia.